These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 29246495

  • 21. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
    Lee JS, Lee JY, Song DW, Bae HS, Doo HM, Yu HS, Lee KJ, Kim HK, Hwang H, Kwak G, Kim D, Kim S, Hong YB, Lee JM, Choi BO.
    Nucleic Acids Res; 2020 Jan 10; 48(1):130-140. PubMed ID: 31713617
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
    Zhao HT, Damle S, Ikeda-Lee K, Kuntz S, Li J, Mohan A, Kim A, Hung G, Scheideler MA, Scherer SS, Svaren J, Swayze EE, Kordasiewicz HB.
    J Clin Invest; 2018 Jan 02; 128(1):359-368. PubMed ID: 29202483
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
    Fortun J, Li J, Go J, Fenstermaker A, Fletcher BS, Notterpek L.
    J Neurochem; 2005 Mar 02; 92(6):1531-41. PubMed ID: 15748170
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder.
    Duchesne M, Danigo A, Richard L, Vallat JM, Attarian S, Gonnaud PM, Lacour A, Péréon Y, Stojkovic T, Nave KA, Bertrand V, Nabirotchkin S, Cohen D, Demiot C, Magy L.
    J Neuropathol Exp Neurol; 2018 Apr 01; 77(4):274-281. PubMed ID: 29408953
    [Abstract] [Full Text] [Related]

  • 30. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
    Sociali G, Visigalli D, Prukop T, Cervellini I, Mannino E, Venturi C, Bruzzone S, Sereda MW, Schenone A.
    Neurobiol Dis; 2016 Nov 01; 95():145-57. PubMed ID: 27431093
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW.
    Ann Neurol; 2007 Jan 01; 61(1):61-72. PubMed ID: 17262851
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
    D'Urso D, Prior R, Greiner-Petter R, Gabreëls-Festen AA, Müller HW.
    J Neurosci; 1998 Jan 15; 18(2):731-40. PubMed ID: 9425015
    [Abstract] [Full Text] [Related]

  • 37. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside.
    Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, Ianakova E, Wu X, Schenone A, Vallat JM, Kupsky WJ, Hatfield J, Shy ME.
    Brain; 2005 May 15; 128(Pt 5):1168-77. PubMed ID: 15774502
    [Abstract] [Full Text] [Related]

  • 38. Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease.
    Madorsky I, Opalach K, Waber A, Verrier JD, Solmo C, Foster T, Dunn WA, Notterpek L.
    Neurobiol Dis; 2009 Apr 15; 34(1):146-54. PubMed ID: 19320048
    [Abstract] [Full Text] [Related]

  • 39. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S, Young P, Suter U.
    Brain; 2001 Nov 15; 124(Pt 11):2177-87. PubMed ID: 11673320
    [Abstract] [Full Text] [Related]

  • 40. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S, Scherer SS, Nave KA, Suter U.
    J Neurosci Res; 2002 Feb 15; 67(4):443-9. PubMed ID: 11835311
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.